High profit margins aren't a problem when there is a significant value add. Moderna is taking extremely inexpensive bulk chemicals and turning them into much more valuable finished medicines. Of course there is significant capital cost - research, equipment, dealing with regulatory bodies, etc but once all that is paid for pharma is basically a money printer.